

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular ketone body metabolic process (GO:0046950) | 6.97551690 |
| 2 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 6.33672866 |
| 3 | ketone body metabolic process (GO:1902224) | 6.17385492 |
| 4 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.87773089 |
| 5 | neuron remodeling (GO:0016322) | 4.80528766 |
| 6 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.77764248 |
| 7 | negative regulation of neurotransmitter transport (GO:0051589) | 4.41492962 |
| 8 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.18502894 |
| 9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.16984850 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.14192601 |
| 11 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.06503653 |
| 12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.95860311 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.94923560 |
| 14 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.88923751 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.87807250 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 3.85922825 |
| 17 | postsynaptic membrane organization (GO:0001941) | 3.83862562 |
| 18 | nerve growth factor signaling pathway (GO:0038180) | 3.80183024 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 3.62604937 |
| 20 | regulation of membrane repolarization (GO:0060306) | 3.58423394 |
| 21 | positive regulation of neurotransmitter transport (GO:0051590) | 3.55669866 |
| 22 | striatum development (GO:0021756) | 3.52740534 |
| 23 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.48212514 |
| 24 | presynaptic membrane assembly (GO:0097105) | 3.47084007 |
| 25 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.46215411 |
| 26 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.45391036 |
| 27 | cardiac myofibril assembly (GO:0055003) | 3.44625890 |
| 28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.42249356 |
| 29 | cell communication involved in cardiac conduction (GO:0086065) | 3.42242656 |
| 30 | regulation of pigment cell differentiation (GO:0050932) | 3.37548650 |
| 31 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.36622320 |
| 32 | negative regulation of granulocyte differentiation (GO:0030853) | 3.35708799 |
| 33 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.34648864 |
| 34 | cell communication by electrical coupling (GO:0010644) | 3.33731352 |
| 35 | peristalsis (GO:0030432) | 3.31113386 |
| 36 | presynaptic membrane organization (GO:0097090) | 3.30110277 |
| 37 | forebrain neuron development (GO:0021884) | 3.29274466 |
| 38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.26126755 |
| 39 | dopamine receptor signaling pathway (GO:0007212) | 3.25345769 |
| 40 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.24970369 |
| 41 | positive regulation of sodium ion transport (GO:0010765) | 3.23672130 |
| 42 | sarcomere organization (GO:0045214) | 3.23414509 |
| 43 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.22296828 |
| 44 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.18604358 |
| 45 | stress granule assembly (GO:0034063) | 3.18390049 |
| 46 | neuromuscular synaptic transmission (GO:0007274) | 3.17868404 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.14915789 |
| 48 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11775077 |
| 49 | response to inactivity (GO:0014854) | 3.09858660 |
| 50 | detection of calcium ion (GO:0005513) | 3.09780629 |
| 51 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.08314139 |
| 52 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08203335 |
| 53 | cardiac muscle contraction (GO:0060048) | 3.07876906 |
| 54 | action potential (GO:0001508) | 3.03799899 |
| 55 | positive regulation of heart rate (GO:0010460) | 3.02236413 |
| 56 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.02099551 |
| 57 | negative regulation of circadian rhythm (GO:0042754) | 3.01933467 |
| 58 | vocalization behavior (GO:0071625) | 3.01882982 |
| 59 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.01668285 |
| 60 | cardiac ventricle formation (GO:0003211) | 3.01048999 |
| 61 | maternal behavior (GO:0042711) | 2.99042903 |
| 62 | cardiac muscle hypertrophy (GO:0003300) | 2.98493410 |
| 63 | regulation of female receptivity (GO:0045924) | 2.97026372 |
| 64 | cardiac chamber formation (GO:0003207) | 2.96796993 |
| 65 | serotonin metabolic process (GO:0042428) | 2.95008658 |
| 66 | myofibril assembly (GO:0030239) | 2.93529696 |
| 67 | neuron cell-cell adhesion (GO:0007158) | 2.92193770 |
| 68 | dendritic spine morphogenesis (GO:0060997) | 2.89953335 |
| 69 | regulation of neurotransmitter transport (GO:0051588) | 2.89546744 |
| 70 | organ growth (GO:0035265) | 2.89005853 |
| 71 | cellular response to epinephrine stimulus (GO:0071872) | 2.88773828 |
| 72 | regulation of cell communication by electrical coupling (GO:0010649) | 2.88690953 |
| 73 | regulation of neurotransmitter uptake (GO:0051580) | 2.88540811 |
| 74 | muscle filament sliding (GO:0030049) | 2.86107655 |
| 75 | actin-myosin filament sliding (GO:0033275) | 2.86107655 |
| 76 | striated muscle hypertrophy (GO:0014897) | 2.84529623 |
| 77 | heart contraction (GO:0060047) | 2.84124759 |
| 78 | heart process (GO:0003015) | 2.84124759 |
| 79 | cardiac muscle cell action potential (GO:0086001) | 2.83630698 |
| 80 | regulation of heart rate (GO:0002027) | 2.83437974 |
| 81 | adrenergic receptor signaling pathway (GO:0071875) | 2.83137583 |
| 82 | homocysteine metabolic process (GO:0050667) | 2.82767177 |
| 83 | positive regulation of dendritic spine development (GO:0060999) | 2.82020131 |
| 84 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.80713828 |
| 85 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.79900087 |
| 86 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79512710 |
| 87 | urinary tract smooth muscle contraction (GO:0014848) | 2.78535320 |
| 88 | transmission of nerve impulse (GO:0019226) | 2.76722261 |
| 89 | response to epinephrine (GO:0071871) | 2.76279180 |
| 90 | regulation of neurotransmitter secretion (GO:0046928) | 2.76134950 |
| 91 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.74883845 |
| 92 | regulation of striated muscle contraction (GO:0006942) | 2.74635128 |
| 93 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.74128014 |
| 94 | neuronal action potential (GO:0019228) | 2.72683532 |
| 95 | auditory behavior (GO:0031223) | 2.72480457 |
| 96 | membrane depolarization during action potential (GO:0086010) | 2.72354430 |
| 97 | dendrite development (GO:0016358) | 2.71452071 |
| 98 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.71235278 |
| 99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.69865671 |
| 100 | thalamus development (GO:0021794) | 2.69136583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.49434238 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.28055116 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.79508337 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.62365263 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57824621 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53331697 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.47718283 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38119854 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38119854 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37270575 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31401932 |
| 12 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27983426 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16422749 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15539529 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06424532 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05425994 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01923256 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.97691530 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97090946 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.96729091 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.96712604 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.96085775 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91240700 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.90909560 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89145293 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.87233745 |
| 27 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.81052132 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.79687400 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77911346 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65233973 |
| 31 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.62134588 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61860908 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58272248 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53442149 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50805872 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50693416 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50400392 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50189261 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45812225 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45753373 |
| 41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.44247018 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43244120 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37909222 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35824688 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33861221 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33080303 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31681512 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31409685 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.31002739 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29384012 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28718554 |
| 52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25858868 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25484837 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24680813 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22088623 |
| 56 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20272069 |
| 57 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.19133694 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19121986 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19105437 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.18533488 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18434204 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17893836 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17027701 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16635646 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14769161 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12782663 |
| 67 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12463791 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12307255 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11915470 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11175160 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.10157489 |
| 72 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09763420 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09341288 |
| 74 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08515972 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07134980 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06427763 |
| 77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05914126 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04641640 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03557392 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02704026 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02120632 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00110836 |
| 83 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.99811133 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99199133 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99199133 |
| 86 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.98246492 |
| 87 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96894377 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96828548 |
| 89 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96349343 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94088677 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93324873 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92906745 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91301173 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90490397 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90483930 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90483930 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90190497 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90179575 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88847037 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88653431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 7.12339240 |
| 2 | MP0005409_darkened_coat_color | 4.23026863 |
| 3 | MP0001188_hyperpigmentation | 4.00078043 |
| 4 | MP0003880_abnormal_central_pattern | 3.84631068 |
| 5 | MP0003646_muscle_fatigue | 3.16172203 |
| 6 | MP0000751_myopathy | 2.58218415 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.56131139 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.49503312 |
| 9 | MP0003283_abnormal_digestive_organ | 2.36193778 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.14789571 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.12556019 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.10819574 |
| 13 | MP0003122_maternal_imprinting | 2.06302740 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.05781328 |
| 15 | MP0004043_abnormal_pH_regulation | 1.96380863 |
| 16 | MP0004084_abnormal_cardiac_muscle | 1.95609467 |
| 17 | MP0004510_myositis | 1.95101192 |
| 18 | MP0001529_abnormal_vocalization | 1.92256979 |
| 19 | MP0004130_abnormal_muscle_cell | 1.88757303 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.82073500 |
| 21 | MP0000015_abnormal_ear_pigmentation | 1.78686146 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 1.77911904 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.76572174 |
| 24 | MP0001486_abnormal_startle_reflex | 1.71672739 |
| 25 | MP0000372_irregular_coat_pigmentation | 1.68161872 |
| 26 | MP0002234_abnormal_pharynx_morphology | 1.65750251 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.65557482 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.62837352 |
| 29 | MP0002064_seizures | 1.62618250 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.57117091 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.55723799 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.54744849 |
| 33 | MP0009745_abnormal_behavioral_response | 1.53648010 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.52493058 |
| 35 | MP0002272_abnormal_nervous_system | 1.50881460 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.48076610 |
| 37 | MP0003137_abnormal_impulse_conducting | 1.48024158 |
| 38 | MP0004233_abnormal_muscle_weight | 1.45483047 |
| 39 | MP0004885_abnormal_endolymph | 1.41516276 |
| 40 | MP0000778_abnormal_nervous_system | 1.39580043 |
| 41 | MP0004484_altered_response_of | 1.38276832 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.37600144 |
| 43 | MP0009046_muscle_twitch | 1.36074661 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.34070037 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.29671592 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.25197113 |
| 47 | MP0005369_muscle_phenotype | 1.23101466 |
| 48 | MP0002127_abnormal_cardiovascular_syste | 1.18813613 |
| 49 | MP0003136_yellow_coat_color | 1.16252807 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.14834503 |
| 51 | MP0001984_abnormal_olfaction | 1.10496658 |
| 52 | MP0001544_abnormal_cardiovascular_syste | 1.10412226 |
| 53 | MP0005385_cardiovascular_system_phenoty | 1.10412226 |
| 54 | MP0006138_congestive_heart_failure | 1.10127892 |
| 55 | MP0002184_abnormal_innervation | 1.08029883 |
| 56 | MP0000749_muscle_degeneration | 1.02211407 |
| 57 | MP0004087_abnormal_muscle_fiber | 1.00780578 |
| 58 | MP0005670_abnormal_white_adipose | 0.99706357 |
| 59 | MP0004270_analgesia | 0.97845951 |
| 60 | MP0004085_abnormal_heartbeat | 0.97253097 |
| 61 | MP0004142_abnormal_muscle_tone | 0.95116681 |
| 62 | MP0002067_abnormal_sensory_capabilities | 0.92479422 |
| 63 | MP0008569_lethality_at_weaning | 0.92149460 |
| 64 | MP0002557_abnormal_social/conspecific_i | 0.91645592 |
| 65 | MP0004147_increased_porphyrin_level | 0.89730136 |
| 66 | MP0003690_abnormal_glial_cell | 0.82875038 |
| 67 | MP0002066_abnormal_motor_capabilities/c | 0.79683732 |
| 68 | MP0005171_absent_coat_pigmentation | 0.79019323 |
| 69 | MP0003045_fibrosis | 0.77950833 |
| 70 | MP0000343_altered_response_to | 0.77612824 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.77142467 |
| 72 | MP0008775_abnormal_heart_ventricle | 0.76921857 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 0.76869782 |
| 74 | MP0001764_abnormal_homeostasis | 0.75866321 |
| 75 | MP0002882_abnormal_neuron_morphology | 0.74627103 |
| 76 | MP0004924_abnormal_behavior | 0.72022207 |
| 77 | MP0005386_behavior/neurological_phenoty | 0.72022207 |
| 78 | MP0000026_abnormal_inner_ear | 0.70754439 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70430566 |
| 80 | MP0002163_abnormal_gland_morphology | 0.70350368 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.69658624 |
| 82 | MP0001968_abnormal_touch/_nociception | 0.69419984 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 0.69053801 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.68843757 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.68779745 |
| 86 | MP0003119_abnormal_digestive_system | 0.66656483 |
| 87 | MP0005535_abnormal_body_temperature | 0.66350458 |
| 88 | MP0002822_catalepsy | 0.65999529 |
| 89 | MP0002735_abnormal_chemical_nociception | 0.65558458 |
| 90 | MP0010368_abnormal_lymphatic_system | 0.65542411 |
| 91 | MP0001664_abnormal_digestion | 0.65102016 |
| 92 | MP0008995_early_reproductive_senescence | 0.63040499 |
| 93 | MP0001440_abnormal_grooming_behavior | 0.62696233 |
| 94 | MP0000371_diluted_coat_color | 0.61996372 |
| 95 | MP0004811_abnormal_neuron_physiology | 0.61263783 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61125560 |
| 97 | MP0000955_abnormal_spinal_cord | 0.61019877 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.60344077 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.59426812 |
| 100 | MP0002152_abnormal_brain_morphology | 0.58876646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ketoacidosis (HP:0001993) | 5.41576528 |
| 2 | Methylmalonic acidemia (HP:0002912) | 5.39225406 |
| 3 | Sudden death (HP:0001699) | 4.42839813 |
| 4 | Skin nodule (HP:0200036) | 4.34142920 |
| 5 | Bundle branch block (HP:0011710) | 4.03230043 |
| 6 | Facial hemangioma (HP:0000329) | 3.91882789 |
| 7 | Syncope (HP:0001279) | 3.88747802 |
| 8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.88522150 |
| 9 | Abnormality of DNA repair (HP:0003254) | 3.86140898 |
| 10 | Abnormality of vitamin B metabolism (HP:0004340) | 3.67155781 |
| 11 | Atrial fibrillation (HP:0005110) | 3.63485590 |
| 12 | Myokymia (HP:0002411) | 3.62256930 |
| 13 | Chronic hepatic failure (HP:0100626) | 3.61054985 |
| 14 | Delayed CNS myelination (HP:0002188) | 3.53018722 |
| 15 | Methylmalonic aciduria (HP:0012120) | 3.48857728 |
| 16 | Metaphyseal dysplasia (HP:0100255) | 3.48041895 |
| 17 | Ketosis (HP:0001946) | 3.47524515 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.46554305 |
| 19 | Ventricular tachycardia (HP:0004756) | 3.43443937 |
| 20 | Atrioventricular block (HP:0001678) | 3.38211501 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 3.35354416 |
| 22 | Ventricular arrhythmia (HP:0004308) | 3.30284152 |
| 23 | Supraventricular tachycardia (HP:0004755) | 3.17320050 |
| 24 | Hyperglycinemia (HP:0002154) | 3.11223252 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 3.10065623 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 3.07688031 |
| 27 | Ventricular fibrillation (HP:0001663) | 3.07386548 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.05729536 |
| 29 | Heart block (HP:0012722) | 3.05273623 |
| 30 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.03894130 |
| 31 | Tachypnea (HP:0002789) | 3.03863930 |
| 32 | Choroideremia (HP:0001139) | 3.03270355 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 2.95890658 |
| 34 | Prolonged QT interval (HP:0001657) | 2.87110657 |
| 35 | EEG with generalized epileptiform discharges (HP:0011198) | 2.73787802 |
| 36 | Bradycardia (HP:0001662) | 2.71934575 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 2.69500427 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 2.68790319 |
| 39 | Palpitations (HP:0001962) | 2.68614414 |
| 40 | Hypsarrhythmia (HP:0002521) | 2.67525864 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 2.63452988 |
| 42 | Focal seizures (HP:0007359) | 2.61761755 |
| 43 | Homocystinuria (HP:0002156) | 2.60869508 |
| 44 | Abnormality of homocysteine metabolism (HP:0010919) | 2.60869508 |
| 45 | Myotonia (HP:0002486) | 2.58116019 |
| 46 | Abnormality of vitamin metabolism (HP:0100508) | 2.52785848 |
| 47 | Tongue fasciculations (HP:0001308) | 2.52584894 |
| 48 | Abnormal EKG (HP:0003115) | 2.49446230 |
| 49 | Abnormality of the metopic suture (HP:0005556) | 2.48583837 |
| 50 | Amelogenesis imperfecta (HP:0000705) | 2.44214092 |
| 51 | Muscle fibrillation (HP:0010546) | 2.39800318 |
| 52 | Focal motor seizures (HP:0011153) | 2.37282134 |
| 53 | Prominent metopic ridge (HP:0005487) | 2.36667851 |
| 54 | Muscle fiber inclusion bodies (HP:0100299) | 2.36333755 |
| 55 | Subaortic stenosis (HP:0001682) | 2.34329096 |
| 56 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.34329096 |
| 57 | Lipoatrophy (HP:0100578) | 2.28932632 |
| 58 | Megaloblastic anemia (HP:0001889) | 2.26647998 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.24791424 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.24791424 |
| 61 | Albinism (HP:0001022) | 2.24045063 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.23336182 |
| 63 | Delayed myelination (HP:0012448) | 2.20878990 |
| 64 | Conjunctival telangiectasia (HP:0000524) | 2.20598203 |
| 65 | EMG: myopathic abnormalities (HP:0003458) | 2.15583188 |
| 66 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.14020951 |
| 67 | Hypothermia (HP:0002045) | 2.12985643 |
| 68 | Limb hypertonia (HP:0002509) | 2.12013211 |
| 69 | Nemaline bodies (HP:0003798) | 2.07799832 |
| 70 | Increased hepatocellular lipid droplets (HP:0006565) | 2.06646886 |
| 71 | Lower limb asymmetry (HP:0100559) | 2.05122573 |
| 72 | Left ventricular hypertrophy (HP:0001712) | 2.03830825 |
| 73 | Heterochromia iridis (HP:0001100) | 2.02623738 |
| 74 | Generalized tonic-clonic seizures (HP:0002069) | 2.00916178 |
| 75 | Ankle clonus (HP:0011448) | 1.96210268 |
| 76 | Buphthalmos (HP:0000557) | 1.95985423 |
| 77 | Broad alveolar ridges (HP:0000187) | 1.95304221 |
| 78 | Adactyly (HP:0009776) | 1.95254671 |
| 79 | Exercise-induced myalgia (HP:0003738) | 1.94471708 |
| 80 | Febrile seizures (HP:0002373) | 1.92289972 |
| 81 | Hypoplastic pelvis (HP:0008839) | 1.91150294 |
| 82 | Lymphangioma (HP:0100764) | 1.86619920 |
| 83 | Atonic seizures (HP:0010819) | 1.85613468 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82584500 |
| 85 | Frequent falls (HP:0002359) | 1.80771392 |
| 86 | Exercise-induced muscle cramps (HP:0003710) | 1.77846889 |
| 87 | Type 1 muscle fiber predominance (HP:0003803) | 1.77542567 |
| 88 | Hyperventilation (HP:0002883) | 1.76349846 |
| 89 | Dilated cardiomyopathy (HP:0001644) | 1.72965236 |
| 90 | Hypoglycemic coma (HP:0001325) | 1.71021525 |
| 91 | Neck muscle weakness (HP:0000467) | 1.67109196 |
| 92 | Incomplete penetrance (HP:0003829) | 1.66924346 |
| 93 | Epileptic encephalopathy (HP:0200134) | 1.65172326 |
| 94 | Gout (HP:0001997) | 1.61073787 |
| 95 | Neonatal onset (HP:0003623) | 1.60991957 |
| 96 | Abnormality of glycine metabolism (HP:0010895) | 1.60975533 |
| 97 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.60975533 |
| 98 | Abnormality of the ischium (HP:0003174) | 1.60462268 |
| 99 | Muscular hypotonia of the trunk (HP:0008936) | 1.59604280 |
| 100 | Hypoplastic ischia (HP:0003175) | 1.59194614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.04000999 |
| 2 | MARK1 | 3.87131063 |
| 3 | OBSCN | 3.35412273 |
| 4 | MAP4K2 | 2.84274051 |
| 5 | PHKG1 | 2.47717182 |
| 6 | PHKG2 | 2.47717182 |
| 7 | NTRK2 | 2.42500926 |
| 8 | BLK | 2.30020140 |
| 9 | EPHA4 | 2.24761863 |
| 10 | AKT3 | 2.09074569 |
| 11 | DMPK | 1.99207615 |
| 12 | PINK1 | 1.88132457 |
| 13 | PAK3 | 1.75743887 |
| 14 | TTN | 1.70119008 |
| 15 | MAPK13 | 1.67398342 |
| 16 | EPHB2 | 1.66593814 |
| 17 | MAP2K4 | 1.63155243 |
| 18 | MAP2K3 | 1.56179277 |
| 19 | NTRK3 | 1.56162273 |
| 20 | VRK2 | 1.53237797 |
| 21 | MUSK | 1.46383166 |
| 22 | MAP3K6 | 1.45605341 |
| 23 | WNK3 | 1.45374088 |
| 24 | MAP3K9 | 1.43438204 |
| 25 | STK11 | 1.29940690 |
| 26 | GRK1 | 1.28754166 |
| 27 | DYRK2 | 1.28012881 |
| 28 | RPS6KA6 | 1.27311740 |
| 29 | RPS6KL1 | 1.24120527 |
| 30 | RPS6KC1 | 1.24120527 |
| 31 | ERN1 | 1.21497428 |
| 32 | MAP3K4 | 1.17810659 |
| 33 | PAK6 | 1.08844839 |
| 34 | TAOK1 | 1.04427224 |
| 35 | CAMK4 | 1.02298274 |
| 36 | CAMK1 | 1.02072477 |
| 37 | ICK | 1.01885872 |
| 38 | CAMK2A | 1.00985190 |
| 39 | PNCK | 0.98761523 |
| 40 | MAP2K7 | 0.94472687 |
| 41 | CAMK2B | 0.92795081 |
| 42 | BRAF | 0.92388892 |
| 43 | LATS2 | 0.92012474 |
| 44 | PRKD3 | 0.91550872 |
| 45 | SGK2 | 0.90135377 |
| 46 | CDK9 | 0.89836508 |
| 47 | MINK1 | 0.88583790 |
| 48 | GRK5 | 0.86867250 |
| 49 | DAPK2 | 0.86284597 |
| 50 | EEF2K | 0.84811184 |
| 51 | UHMK1 | 0.84062363 |
| 52 | CAMK2D | 0.84013681 |
| 53 | MAPKAPK5 | 0.82026156 |
| 54 | WNK4 | 0.81900130 |
| 55 | MAPK12 | 0.77628415 |
| 56 | PKN1 | 0.75432312 |
| 57 | MAP3K11 | 0.74892541 |
| 58 | KSR1 | 0.74408045 |
| 59 | MAPK4 | 0.73798114 |
| 60 | RPS6KA2 | 0.72730952 |
| 61 | LMTK2 | 0.72592655 |
| 62 | MYLK | 0.72179972 |
| 63 | SGK494 | 0.70258867 |
| 64 | SGK223 | 0.70258867 |
| 65 | EPHA3 | 0.64455208 |
| 66 | MAP2K6 | 0.63341865 |
| 67 | PRKACA | 0.62815595 |
| 68 | ALK | 0.61870338 |
| 69 | ADRBK2 | 0.61662236 |
| 70 | NTRK1 | 0.59464291 |
| 71 | MAP2K1 | 0.59135262 |
| 72 | PRKACG | 0.56166146 |
| 73 | RPS6KA3 | 0.55807771 |
| 74 | PRKCE | 0.54411537 |
| 75 | MAP3K7 | 0.54133864 |
| 76 | VRK1 | 0.53075649 |
| 77 | STK39 | 0.51657494 |
| 78 | SCYL2 | 0.51654228 |
| 79 | CDK5 | 0.50914129 |
| 80 | PRKCG | 0.50173092 |
| 81 | RPS6KB2 | 0.49618969 |
| 82 | PIK3CA | 0.45198045 |
| 83 | TNIK | 0.44540864 |
| 84 | TRPM7 | 0.43764097 |
| 85 | DYRK1B | 0.41727127 |
| 86 | CDK15 | 0.41278159 |
| 87 | BCKDK | 0.40524342 |
| 88 | PRKCZ | 0.40102822 |
| 89 | MAPK15 | 0.39224275 |
| 90 | PRKG1 | 0.38930492 |
| 91 | PRKAA1 | 0.38887218 |
| 92 | DYRK1A | 0.38879488 |
| 93 | AKT2 | 0.38714216 |
| 94 | PDPK1 | 0.38635784 |
| 95 | PRKCH | 0.37850719 |
| 96 | TIE1 | 0.36753059 |
| 97 | CDK11A | 0.36123124 |
| 98 | INSRR | 0.36081288 |
| 99 | ARAF | 0.35654963 |
| 100 | CSNK1G2 | 0.35310561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 6.85573653 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.50450017 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50419909 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.37268777 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.32004035 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.18305657 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.15237044 |
| 8 | Salivary secretion_Homo sapiens_hsa04970 | 2.06274069 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.99890105 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.97213355 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94208697 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 1.92436892 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.88443395 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.86559842 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.82261471 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79314856 |
| 17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.62477177 |
| 18 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.61380292 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60906040 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60464231 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.52087495 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49160244 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48912537 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.47958630 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42194344 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.40801672 |
| 27 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.39514229 |
| 28 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30300132 |
| 29 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.29868248 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.28388681 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.28302957 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26213355 |
| 33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.24198736 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22448105 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20223316 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16952886 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.16228521 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12343746 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06001116 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04819390 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02082074 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00483234 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98424365 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.96435853 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95687914 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94600357 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93929930 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92780922 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92725925 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91311202 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90386128 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84738861 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 0.84693921 |
| 54 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83517436 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83450249 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82942828 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.82188534 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79187364 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78122766 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77617655 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76713954 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74624482 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74584762 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73779898 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66016675 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65391902 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61547028 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60446180 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60187880 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58118401 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58047969 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55328473 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54813069 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52986366 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51631334 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51593670 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49515123 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.49318657 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.48740788 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47161118 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.46755264 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46080692 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44175892 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43861656 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42735738 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42663563 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42079674 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39485747 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39212585 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37014590 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35127018 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.34564946 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33921105 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31776781 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31729640 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30749491 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.29553069 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28570466 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.28503497 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.27462140 |

